RAKIN KEVIN 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Feb 22, 2022
Insider Transaction Report
Form 4
RAKIN KEVIN
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2022-02-17−6,667→ 0 totalExercise: $4.80From: 2020-12-30Exp: 2030-01-08→ Common Stock (6,667 underlying) - Tax Payment
Common Stock
2022-02-17$10.63/sh−3,010$31,996→ 56,661 total - Exercise/Conversion
Common Stock
2022-02-17$4.80/sh+6,667$32,002→ 59,671 total
Footnotes (1)
- [F1]Represents a cashless exercise of outstanding stock options to purchase 6,667 shares of common stock. The reporting person received 3,657 shares of common stock and surrendered 3,010 shares of common stock underlying the stock option in payment of the exercise price.